Logatiman, Ana Marie C.
HRN: 21-42-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2022
METRONIDAZOLE 500MG (TAB)
05/18/2022
05/24/2022
ORAL
500mg
TID
S/P RMLE 4th Degree Laceration
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes